MyFinsight
Home
Blog
About
Contact
Download
Download image
Non Us
$140,100K
US
$285,300K
Eylea Net Product
Sales
$576,900K
ELYEAHD
$506,300K
Other Products
$3,100K
Inmazeb-US
$9,350K
Evkeeza-US
$47,300K
Praluent Net Product
Sales-US
$72,200K
LIBTAYONet Product Sales
$425,400K
ELYEAHDAnd EYLEA-US
$1,083,200K
Product And Service
Other
$238,600K
Collaboration Revenue
$1,970,900K
Product
$1,674,800K
Other income
(expense), net
$176,000K
Revenue from contract
with customer
$3,884,300K
Total other income
(expense)
$163,800K
Income from operations
$879,900K
Interest expense
$12,200K
Total expenses
$3,004,400K
Income before income
taxes
$1,043,700K
Cost of goods sold and
of collaboration...
$265,900K
Cost of goods sold and
of collaboration...
$318,700K
Selling, general, and
administrative
$775,000K
Acquired in-process
research and development
$18,700K
Research and development
$1,626,100K
Gain (loss) on
foreign currency...
$1,400K
Unrealized gain on debt
securities
$7,100K
Net income
$844,600K
Income tax expense
$199,100K
Comprehensive income
$853,100K
Back
Back
Income Statement
source: myfinsight.com
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)